These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18636787)

  • 1. Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions.
    Hägg S; Bate A; Stahl M; Spigset O
    Drug Saf; 2008; 31(8):685-94. PubMed ID: 18636787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacovigilance study of the association between antipsychotic drugs and venous thromboembolism based on Food and Drug Administration Adverse Event Reporting System data.
    Yan Y; Wang L; Yuan Y; Xu J; Chen Y; Wu B
    Expert Opin Drug Saf; 2024 Jun; 23(6):771-776. PubMed ID: 37615268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose intolerance with atypical antipsychotics.
    Hedenmalm K; Hägg S; Ståhl M; Mortimer O; Spigset O
    Drug Saf; 2002; 25(15):1107-16. PubMed ID: 12452735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.
    Jönsson AK; Spigset O; Hägg S
    CNS Drugs; 2012 Aug; 26(8):649-62. PubMed ID: 22731933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of venous thromboembolism during treatment with antipsychotic agents.
    Masopust J; Malý R; Vališ M
    Psychiatry Clin Neurosci; 2012 Dec; 66(7):541-52. PubMed ID: 23252920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis.
    Baker RA; Pikalov A; Tran QV; Kremenets T; Arani RB; Doraiswamy PM
    Psychopharmacol Bull; 2009; 42(1):11-31. PubMed ID: 19204649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association and Influencing Factors between Antipsychotics Exposure and the Risk of VTE and PE: A Systematic Review and Meta-analysis.
    Dai L; Zuo Q; Chen F; Chen L; Shen Y
    Curr Drug Targets; 2020; 21(9):930-942. PubMed ID: 32321400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic complications of treatment with antipsychotic drugs.
    Shulman M; Jennifer Njoku I; Manu P
    Minerva Med; 2013 Apr; 104(2):175-84. PubMed ID: 23514994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
    Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database.
    de Filippis R; Kane JM; Arzenton E; Moretti U; Raschi E; Trifirò G; Barbui C; De Fazio P; Gastaldon C; Schoretsanitis G
    Drug Saf; 2024 Aug; 47(8):745-757. PubMed ID: 38722481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence.
    Jönsson AK; Schill J; Olsson H; Spigset O; Hägg S
    CNS Drugs; 2018 Jan; 32(1):47-64. PubMed ID: 29423659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
    Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
    Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four cases of venous thromboembolism associated with olanzapine.
    Maly R; Masopust J; Hosak L; Urban A
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):116-8. PubMed ID: 19067990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of medication in early psychosis: a comparison between second-generation and low-dose first-generation antipsychotics.
    Opjordsmoen S; Melle I; Friis S; Haahr U; Johannessen JO; Larsen TK; Rund BR; Simonsen E; Vaglum P; McGlashan TH
    Early Interv Psychiatry; 2009 Feb; 3(1):58-65. PubMed ID: 21352176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.
    Leucht S; Pitschel-Walz G; Abraham D; Kissling W
    Schizophr Res; 1999 Jan; 35(1):51-68. PubMed ID: 9988841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics and venous thromboembolism risk: a meta-analysis.
    Zhang R; Dong L; Shao F; Tan X; Ying K
    Pharmacopsychiatry; 2011 Jul; 44(5):183-8. PubMed ID: 21739416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Venous Thromboembolism Among Commonly Prescribed Second-Generation Antipsychotics.
    Paulmann R; Backe K; Pinsonnault J; Humble M; Kelly K
    J Pharm Pract; 2024 Aug; 37(4):845-853. PubMed ID: 37347841
    [No Abstract]   [Full Text] [Related]  

  • 20. Antipsychotic use and Risk of Venous Thromboembolism: A Meta-Analysis.
    Di X; Chen M; Shen S; Cui X
    Psychiatry Res; 2021 Feb; 296():113691. PubMed ID: 33421839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.